News : pharmaceutical

View:
 

Found press releases

 

Syntagon Restructures to Further Improve Drug Substance Development Offering

12/22/2011 7:16 AM EST  -   Syntagon
Leading contract research provider, Syntagon, is set to implement a restructuring programme designed to further improve its offering to customers in the field of drug substance development.
Syntagon’s Sweden-based operations (Syntagon AB) will focus and strengthen its customer-oriented expertise within drug substance development, quality assurance and regulatory support, while the Group’s Latvian site (SIA...
Anders Högdin
 

Syntagon Technical Director to Deliver Speech on Guaranteed CMC(s) Approval at C...

9/29/2011 8:00 AM EST  -   Syntagon
Syntagon’s Technical Director, Dr. Anders Högdin, is set to deliver a presentation entitled "CMC(s) Approval Guaranteed" at the upcoming CPhI Worldwide exhibition in Frankfurt, Germany.
Syntagon is the only CRO that offers Guaranteed CMC(s) approval from regulatory authorities. Dr. Högdin’s speech will explore current regulatory requirements for drug substances in IMPD or IND submission, what the regulatory...

EmPower Research shares new perspectives on online influencers at ExL 2nd Digita...

6/30/2011 12:54 PM EST  -   EmPower Research
SAN FRANCISCO, CA, JUNE 30, 2011 – Following the recent launch of its Social Media-based Online KOL solution, EmPower Research shared new perspectives on online influencers at the ExL 2ndDigital Pharma West conference. Speaking at the conference, Debjani Deb, Managing Partner, stressed the absolute need for healthcare and pharmaceutical companies to augment their traditional influencer networks with the fast...

EmPower Research Launches Social Media-based Online Influencer Solution For Heal...

6/23/2011 12:56 PM EST  -   EmPower Research
NEW YORK, JUNE 23, 2011 – EmPower Research today announced the launch of its Social Media-based solution to identify, profile, track and map online influencers for healthcare and pharmaceutical industries.

“The physician is no longer the only influencer.” said Debjani Deb, Managing Partner. She added, “Traditionally, healthcare and pharmaceutical companies have engaged with physician Key Opinion Leaders (KOL) to...
Clondalkin Group
 

CLONDALKIN GROUP TO ACQUIRE THE PRINTED COMPONENTS BUSINESS OF CATALENT PHARMA S...

2/28/2011 1:29 PM EST  -   Adessi
Clondalkin Group and Catalent Pharma Solutions today announced that Clondalkin has agreed to acquire the Printed Components business of Catalent. Terms of the transaction were not disclosed, and closing is subject to receipt of regulatory approval.

In addition, at closing Clondalkin and Catalent will enter into a long-term supply agreement which ensures that Catalent will continue to be able to provide customers of...

The PM360 Trailblazer Awards Honor Healthcare Marketers and Manufacturers in New...

9/27/2010 4:01 PM EST  -   PM360
New York City, September 27, 2010 — PM360, one of the fastest growing publications in the pharmaceutical and medical device industry, recognized 32 marketers and manufacturers that have blazed a trail for others to follow. The PM360 Trailblazer Awards, which recognizes outstanding achievement and innovation in pharmaceutical/biotech and medical device marketing, was held at the Mandarin Oriental Hotel in New York...

Clondalkin Group targets pharmaceutical and healthcare packaging growth

5/6/2010 10:15 AM EST  -   Adessi
International packaging producer Clondalkin Group has revealed plans to further strengthen its position in the European pharmaceutical and healthcare sector.
Following recent accreditations secured by Boxes Prestige Poland and Harlands Labels Poland, Cahill Printers in Ireland and Harlands Labels in the UK, the Specialist Packaging Division now has eight manufacturing sites across Europe with PS 9000:2000...

MOBERG DERMA RECEIVES GRANT FROM VINNOVA FOR PHARMACEUTICAL PROJECT

11/18/2009 7:30 AM EST  -   MOBERG DERMA AB
The pharmaceutical company Moberg Derma has received a grant of SEK 4,2 million from Vinnova (The Swedish Governmental Agency for Innovation Systems). The grant will be used to develop an innovative patent-protected pharmaceutical product that will further strengthen the company’s position in the area of topical antifungals.
“We are very pleased that we have been awarded this grant which enables a faster...

Syntagon successfully renews GMP accreditation

6/23/2009 8:19 AM EST  -   Syntagon
Specialist contract research organisation, Syntagon, has successfully renewed its Good Manufacturing Practices (GMP) certification for the manufacture of clinical active pharmaceutical ingredients (APIs) following an audit by the Swedish Medical Products Agency.
GMP compliance is an international requirement for the manufacture of medicinal products for human and veterinary use and helps maintain the quality...